Bariatric surgery may confer greater long-term weight loss than semaglutide or tirzepatide for adults with obesity, according to data from a real-world study published in Obesity.Karan R. Chhabra, MD, MSc, assistant professor of surgery and population health at NYU Grossman School of Medicine, said prior studies comparing weight loss with GLP-1 receptor agonists to bariatric surgery tend to be indirect…
Source: Healio News
